Cases 41 - 50 of 1,010
Pfizer Inc. et al v. Aurobindo Pharma Limited
as 1:2023cv01182
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vincerx Pharma, Inc. v. Yourway Transport, Inc.
as 1:2023cv01164
Plaintiff:
Vincerx Pharma, Inc.
Defendant:
Yourway Transport, Inc.
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal
HQ Specialty Pharma Corp. et al v. Amneal Pharmaceuticals LLC
as 1:2023cv01135
Plaintiff:
HQ Specialty Pharma Corp. and WG Critical Care, LLC
Defendant:
Amneal Pharmaceuticals LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al.
as 1:2023cv01103
Counter Defendant:
Bayer Intellectual Property GMBH
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Auson Pharmaceuticals, Inc. and Auson Pharmaceuticals Co., Ltd.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Orphalan SA v. Novitium Pharma LLC
as 1:2023cv01079
Plaintiff:
Orphalan SA
Defendant:
Novitium Pharma LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Afaxys Pharma, LLC v. TherapeuticsMD, Inc.
as 1:2023cv01064
Plaintiff:
Afaxys Pharma, LLC
Counter Claimant:
TherapeuticsMD, Inc.
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal
Piramal Pharma Limited v. Blade Therapeutics, Inc.
as 1:2023cv01044
Plaintiff:
Piramal Pharma Limited doing business as Piramal Pharma Solutions
Defendant:
Blade Therapeutics, Inc.
Cause Of Action: 28 U.S.C. § 1332 Diversity-Breach of Contract
Celgene Corporation et al v. Natco Pharma Limited
as 1:2023cv01019
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Natco Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Zenara Pharma Private Limited
as 1:2023cv00924
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Zenara Pharma Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Aurobindo Pharma Limited
as 1:2023cv00923
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
